Teva Pharmaceutical Industries Ltd. — Proxy Solicitation & Information Statement 2014

Jul 16, 2014

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD10205Corporation no: 520013954Stock Exchange/Market: NYSE310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267267 , 03-9267652 Fax: 03-9267519E.mail address: tomer.amitai@teva.co.ilReported via MAGNA: 16/07/2014              Time of broadcast: 15:37 15:31:29

Reference: 2014-02-115653

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Leading U.S. Proxy Advisory Firm Sapports Teva Nominees and other Shareholders' meeting proposals.
PR_announcing_ISS_support_-_FINAL_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 14/05/2014
- - -
Name of the Signatory: : Bergwerk Dov , Position of Signatory in the reporting corporation: Vice President & General Counsel , Name of Employer Company: .
Basel Telephone: 03-9267513 , Facsimile: 03-9267429 , E-mail: einat.barzilai@teva.co.il 1